Ryuichi Amakawa
- Immunology top 1%
- Oncology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Epidemiology top 10%
- Co-authors
- Shirou FukuharaTomoki� ItoMuneo InabaKayo InabaSusumu IkeharaKenichirou TajimaAndrew WakehamYoshio Ozaki
- Topics
- Lymphoma Diagnosis and Treatment (17 papers)Immunotherapy and Immune Responses (16 papers)Immune Cell Function and Interaction (15 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ryuichi Amakawa
56 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 2.2k
- Oncology 648
- Molecular Biology 638
- Pathology and Forensic Medicine 284
- Epidemiology 265
Countries citing papers authored by Ryuichi Amakawa
This map shows the geographic impact of Ryuichi Amakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Amakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Amakawa more than expected).
Fields of papers citing papers by Ryuichi Amakawa
This network shows the impact of papers produced by Ryuichi Amakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Amakawa. The network helps show where Ryuichi Amakawa may publish in the future.
Co-authorship network of co-authors of Ryuichi Amakawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Amakawa. A scholar is included among the top collaborators of Ryuichi Amakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Amakawa. Ryuichi Amakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 25 | |
| 3 | 18 | |
| 4 | 15 | |
| 5 | 21 | |
| 6 | 19 | |
| 7 | 11 | |
| 8 | 152 | |
| 9 | 14 | |
| 10 | 47 | |
| 11 | 46 | |
| 12 | 360 | |
| 13 | 259 | |
| 14 | 14 | |
| 15 | 254 | |
| 16 | 15 | |
| 17 | 266 | |
| 18 | 55 | |
| 19 | 2 | |
| 20 | Treatment of extranodal lymphoma | 2 |
About Ryuichi Amakawa
Ryuichi Amakawa is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine, having authored 59 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Immunotherapy and Immune Responses (16 papers) and Immune Cell Function and Interaction (15 papers). The work is most often cited by research in Immunology (2.2k citations), Immunology and Allergy (145 citations) and Oncology (648 citations). Ryuichi Amakawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shirou Fukuhara, Tomoki� Ito, Muneo Inaba, Kayo Inaba, Susumu Ikehara, Kenichirou Tajima, Andrew Wakeham, Yoshio Ozaki, Kazutaka Uehira and Thomas M. Kündig. Their work appears in journals such as Cell, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.